Article

Identification of a novel RNA modifications-related model to improve bladder cancer outcomes in the framework of predictive, preventive, and personalized medicine

2022-04-14

Abstract excerpt

<title>Abstract</title> Background Bladder cancer (BCa) is the leading reason for death among malignancies in genitourinary system. RNA modifications participate in pivotal tumor-promoting mechanisms in specific epigenetic contexts. Our study aimed to propose a novel model associated with the “writer” enzymes of five primary RNA adenosine modifications (including m6A, m6Am, m<...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1afe9112-7b16-579b-8779-6c1e7836e7c5
DOI: 10.21203/rs.3.rs-1452102/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of a novel RNA modifications-related model to improve bladder cancer outcomes in the framework of predictive, preventive, and personalized medicineDOI 10.21203/rs.3.rs-1452102/v1Read

Scoring System Based on RNA Modification Writer-Related Genes to Predict Overall Survival and Therapeutic Response in Bladder CancerSemantic proximity Read

Integrative analysis of adenosine-related RNA modifications defines molecular subtypes of bladder cancer and identifies CES1 as a driver of tumor progression and immunotherapy resistance.Semantic proximity Read

N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancerSemantic proximity Read

Integrative machine learning algorithms for developing a consensus RNA modification-based signature for guiding clinical decision-making in bladder cancerSemantic proximity Read

Development of an m6A subtype classifier to guide precision therapy for patients with bladder cancerSemantic proximity Read

N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder CancerSemantic proximity Read

An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancerSemantic proximity Read

5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancerSemantic proximity Read

Integrative Molecular–Radiopathomic Characterization of AIRE-Driven Immune Subtypes in Bladder CancerSemantic proximity Read

Single-cell and bulk RNA-sequence identiﬁed ﬁbroblasts signature and CD8 + T-cell - ﬁbroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine learning: bioinformatics multi-omics studySemantic proximity Read

Identification and Validation of N6-methyladenosine-related Biomarkers for Bladder Cancer: Implications for ImmunotherapySemantic proximity Read

A novel signature based on six autophagy-related genes for prediction of overall survival in bladder cancerSemantic proximity Read